Next Article in Journal
Furcellaran-Coated Microcapsules as Carriers of Cyprinus carpio Skin-Derived Antioxidant Hydrolysate: An In Vitro and In Vivo Study
Previous Article in Journal
Body Mass Index, Lean Mass, and Body Fat Percentage as Mediators of the Relationship between Milk Consumption and Bone Health in Young Adults

Fasting as a Therapy in Neurological Disease

Department of Neurology, Waikato Hospital, Hamilton 3204, New Zealand
Nutrients 2019, 11(10), 2501;
Received: 22 September 2019 / Revised: 12 October 2019 / Accepted: 15 October 2019 / Published: 17 October 2019
Fasting is deeply entrenched in evolution, yet its potential applications to today’s most common, disabling neurological diseases remain relatively unexplored. Fasting induces an altered metabolic state that optimizes neuron bioenergetics, plasticity, and resilience in a way that may counteract a broad array of neurological disorders. In both animals and humans, fasting prevents and treats the metabolic syndrome, a major risk factor for many neurological diseases. In animals, fasting probably prevents the formation of tumors, possibly treats established tumors, and improves tumor responses to chemotherapy. In human cancers, including cancers that involve the brain, fasting ameliorates chemotherapy-related adverse effects and may protect normal cells from chemotherapy. Fasting improves cognition, stalls age-related cognitive decline, usually slows neurodegeneration, reduces brain damage and enhances functional recovery after stroke, and mitigates the pathological and clinical features of epilepsy and multiple sclerosis in animal models. Primarily due to a lack of research, the evidence supporting fasting as a treatment in human neurological disorders, including neurodegeneration, stroke, epilepsy, and multiple sclerosis, is indirect or non-existent. Given the strength of the animal evidence, many exciting discoveries may lie ahead, awaiting future investigations into the viability of fasting as a therapy in neurological disease. View Full-Text
Keywords: fasting; therapy; neurological disease; metabolic syndrome; cancer; neurodegeneration; stroke; epilepsy; multiple sclerosis fasting; therapy; neurological disease; metabolic syndrome; cancer; neurodegeneration; stroke; epilepsy; multiple sclerosis
Show Figures

Figure 1

MDPI and ACS Style

Phillips, M.C.L. Fasting as a Therapy in Neurological Disease. Nutrients 2019, 11, 2501.

AMA Style

Phillips MCL. Fasting as a Therapy in Neurological Disease. Nutrients. 2019; 11(10):2501.

Chicago/Turabian Style

Phillips, Matthew C.L. 2019. "Fasting as a Therapy in Neurological Disease" Nutrients 11, no. 10: 2501.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop